Joint Clinical Trials Office

Pulmonary Segmentectomy for Lung Cancer: A Real-World International Registry-TSOG 108

Clinical Trial Details

This registry study is being done with the Thoracic Surgery Oncology Group (TSOG), which is a collaboration between Memorial Sloan Kettering (MSK) and the American Association for Thoracic Surgery (AATS) to support thoracic surgery clinical trials. We hope to learn more about how different doctors perform the pulmonary segmentectomy surgery and how this type of surgery affects people with lung cancer.

Participants are being asked to join because they will undergo surgery and may or may not have lung cancer.

Participants will complete questionnaires either in the clinic, via telephone call, or via an online link before surgery, 2-4 weeks after surgery, and 6 months after surgery.

Key Eligibility: 

Inclusion Criteria:

  1. 18 years of age or older
  2. Clinical Stage I with suspected non-small cell lung cancer (NSCLC), classified preoperatively (Tissue diagnosis of NSCLC is not required before enrollment. A pathologic diagnosis of NSCLC may be confirmed preoperatively with biopsy, intraoperatively with frozen section, or postoperatively on final pathology.

Exclusion Criteria:

  1.  Actively receiving lung cancer treatment or a history of lung cancer in the previous 5 years
  2. History of chemotherapy or radiation therapy for a previous lung cancer
  3. Synchronous primaries or secondary cancer in the lung or elsewhere in the body at the time of surgery
  4. History of other malignancies within the past 3 years, with the exception of nonmelanoma skin cancer, superficial bladder cancer, hematogenous malignancies, and carcinoma in situ of the cervix
  5. Actively receiving treatment for other malignancies

 Detailed eligibility will be reviewed when contacting the study team.

Return to List

Study contact by location

Upper East Side - Manhattan

Contact(s)

Julissa Murillo
212-746-4528
jum4020@med.cornell.edu

Primary Investigator(s)

Nasser K Altorki, MD

Protocol ID(s)

Weill Cornell Medicine IRB #:

2503028603

ClinicalTrials.gov:

NCT06424327

Sponsor:

Memorial Sloan Kettering Cancer Center

Status

Open to Enrollment

Age Group

Adult

Sponsor

  • Memorial Sloan Kettering Cancer Center

Disease

Lung Cancer